Grants and Contributions:

Title:

UK Multisector - BioM - LV Production Kit: Development of GMP lentiviral production kit with optimized upstream and downstream processes.

Agreement Number:

1034570

Agreement Value:

$354,200.00

Agreement Date:

Sep 1, 2025 - Feb 28, 2027

Description:

As part of the international consortium project “UK Multisector – BioM - LV Production Kit: Development of GMP lentiviral production kit with optimized upstream and downstream processes” this project will develop an end-to-end and off-the-shelf GMP enabled lentivirus manufacturing kit. The current standard in lentivirus manufacturing is inefficient and delivers low yields, leading to elevated manufacturing costs and less accessible therapeutics. This kit will be the first of its kind, integrating innovative upstream and downstream technologies that have been demonstrated to significantly enhance both upstream manufacturing yields and downstream processing recovery and contributing to the greater accessibility of ex-vivo gene therapy.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Ottawa, Ontario, CA K1Z 5N4

Reference Number:

172-2025-2026-Q2-1034570

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

721336089

Recipient Type:

For-profit organization

Recipient's Operating Name:

Virica Biotech

Recipient's Legal Name:

Virica Biotech Inc.

Federal Riding Name:

Ottawa Centre

Federal Riding Number:

35075

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

54171